| Catalog Number |
9-TVLP4F90/060 |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/01/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that on 01 november 2024, a 4f amplatzer torqvue lp delivery system (lot 10353324) was chosen for procedure during a patent ductus arteriosus (pda) closure on a 4-week old, 1.1kg patient.The delivery system was initially used, but it was noted to have a leak at the proximal end of the catheter where the white tubing attaches to the blue catheter.The delivery system was removed, and another 4f amplatzer torqvue lp delivery system (lot 10353324) was prepared, but it was also noted to have a leak at the same spot.A third 4f amplatzer torqvue lp delivery system (lot 10334851) was used to successfully deploy the device.There were no adverse patient effects reported.The patient status was reported as stable.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
| |
|
Event or Problem Description
|
|
It was reported that on (b)(6) 2024, a 4f amplatzer torqvue lp delivery system (lot 10353324 device 1) was chosen for procedure during a patent ductus arteriosus (pda) closure on a 4-week old, 1.1kg patient.The delivery system was prepared.The delivery system was initially used, but it was noted to have a leak at the proximal end of the catheter where the white tubing attaches to the blue catheter.The delivery system was removed, and another 4f amplatzer torqvue lp delivery system (lot 10353324 device 2) was selected for use.During device preparation it was also noted to have a leak at the same spot.The second delivery system (lot 10353324 device 2) did not make contact with the patient.A third 4f amplatzer torqvue lp delivery system (lot 10334851) was used to successfully deploy the device.The patient remained hemodynamically stable throughout the procedure.There was a delay in procedure, but there were no adverse patient effects reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Further information was received indicating the device reported leak occurred during device preparation and did not make contact with the patient.This event no longer meets mdr reporting criteria since the fluid leak was seen prior to the procedure, this may require replacement of the product and would not likely cause or contribute to a patient injury, therefore this is not reportable.Below is the device analysis as an initial report was provided.It was reported that during the device preparation it had a leak at the proximal end of the catheter was reported.The investigation found that the screw part of the extension tube was fractured.Due to the fracture that was found on the screw point of the extension tube, the component was unable to be attached during functional testing.A torquevue catheter subassembly was returned and sent to the s&t (science and technology) testing for analysis.The tests indicated a leak under the strain relief.Upon removing the strain relief, damage breaching the tubing and braiding was noted, which was identified as the likely cause of the leak.As event appears to be related to a potential product quality issue; therefore, the issue is being addressed per internal operating procedures.Abbott will continue to trend the performance of these devices.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications prior to shipment.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|
| |
|
Search Alerts/Recalls
|